Contact UsArabic
Euro Training Center Courses Program
  • Home
  • About Us
    • Who we are
    • Accreditation & Relations
  • Cities
    • Dubai (UAE)
    • Cairo (Egypt)
    • Casablanca (Morocco)
    • Amman (Jordan)
    • London (UK)
    • Sharm El-Sheikh (Egypt)
    • Kuala Lumpur (Malaysia)
    • Istanbul (Turkey)
    • Paris (France)
    • Geneva (Switzerland)
    • Amsterdam (Netherlands)
    • Manama (Bahrain)
    • Rome (Italy)
    • Bangkok (Thailand)
    • Madrid (Spain)
    • Barcelona (Spain)
    • Trabzon (Turkey)
    • Lisbon (Portugal)
    • Munich (Germany)
    • Vienna (Austria)
    • Tbilisi (Georgia)
    • Milan (Italy)
    • Baku (Azerbaijan)
    • Dusseldorf (Germany)
    • Kigali (Rwanda)
    • Doha (Qatar)
    • Nairobi (Kenya)
    • Warsaw (Poland)
    • Riyadh (Saudi Arabia)
    • Jeddah (Saudi Arabia)
    • Lusaka (Zambia)
    • Singapore
    • Tokyo
    • Al Khobar (Saudi Arabia)
    • Cape Town
    • Birmingham (England)
    • Malaga(Spain)
    • Zürich (Switzerland)
    • Vancouver (Canada)
    • Manchester (UK)
    • Boston (USA)
    • Jubail (Saudi Arabia)
    • Oslo (Norway)
    • Florence (Italy)
    • Sydney (Australia)
    • Athens (Greece)
    • Frankfurt (Germany)
    • New York (United State)
    • Abu Dhabi (UAE)
    • Lausanne (Switzerland)
    • Nice (France)
    • Berlin ( Germany)
    • Copenhagen (Denmark)
    • Hanoi (Vietnam)
  • Categories
    • Leadership and Business Management
    • Financial Management and Accounting
    • Human Resources and Talent Development
    • Project and Program Management
    • Sales Marketing Engagement
    • Oil Gas Energy Management
    • Health Safety Environmental Management
    • Conferences
    • Quality Assurance and Auditing
    • Maritime Shipping Port Management
    • Renewable Energy and Sustainability
    • Urban Planning and Smart Cities
    • Banking Financial Services Insurance (BFSI)
    • Governance Risk Compliance (GRC)
    • Information Technology and Digital Systems
    • Office Administration and Executive Support
    • Maintenance Engineering Asset Management
    • Legal Affairs and Contract Management
    • Data Analytics and Business Intelligence
    • Seminars
    • Customer Service and Client Relations
    • Professional Communication and Business Writing
    • Digital Transformation and Innovation
    • Procurement Logistics Supply Chain
    • Personal Development and Workplace Skills
    • Security Operations and Risk Protection
    • Public Relations and Corporate Communication
    • Risk and Crisis Management
    • Tax and Revenue Management
    • Mechanical and Industrial Engineering
    • Agile Methodologies and Business Transformation
    • Strategic Planning and Business Growth
    • Cybersecurity and Information Security
    • Artificial Intelligence and Machine Learning
  • Pro Programs
    • Upcoming
    • Professional
  • Online
Euro training center
info@euro-training.net
Our Main Offices
London, UK
  • +44 7862 132 007
Istanbul, Turkey
  • +90 212 706 92 52
Dubai, UAE
  • +971 503 004 933
  • Privacy Policy
  • Terms & Condition
Copyright Euro Training © 2026
  1. Home
  2. Categories
  3. Governance Risk Compliance (GRC)
  4. Regulatory Affairs Management for Pharmaceuticals and Biologics

Regulatory Affairs Management for Pharmaceuticals and Biologics

RegisterInquiry
Regulatory Affairs Management for Pharmaceuticals and Biologics
Loading...

I4188

Cairo (Egypt)

14 Feb 2027 -18 Feb 2027

4000 €

Overview

Introduction:

Regulatory affairs management ensures that pharmaceutical and biological products comply with quality, safety, efficacy, and regulatory requirements throughout their lifecycle. It encompasses clinical development, product authorization, manufacturing standards, regulatory submissions, and post marketing obligations, including requirements specific to biologics. This training program explores international regulatory frameworks, product classifications, clinical trial requirements, manufacturing compliance, and marketing authorization procedures. It also covers regulatory lifecycle management, pharmacovigilance, inspections, and compliance governance.

Program Objectives:

By the end of this program, participants will be able to:

  • Analyze regulatory frameworks and product classifications for pharmaceuticals and biologics.

  • Examine clinical development requirements and regulatory submission pathways.

  • Evaluate manufacturing standards, quality requirements, and regulatory documentation.

  • Assess marketing authorization procedures and post-approval regulatory obligations.

  • Explore pharmacovigilance, regulatory inspections, and compliance governance.

Targeted Audience:

  • Regulatory Affairs Managers and Specialists.

  • Pharmaceutical and Biotechnology Professionals.

  • Quality Assurance and Quality Control Managers.

  • Clinical Research and Drug Development Professionals.

  • Pharmacovigilance and Regulatory Compliance Professionals.

Program Outline:

Unit 1:

Regulatory Frameworks and Product Classification:

  • International pharmaceutical regulatory frameworks and authority responsibilities.

  • FDA, EMA, and national regulatory requirements.

  • ICH guidelines and regulatory harmonization.

  • Pharmaceutical, biologic, and biosimilar classifications.

  • Regulatory intelligence and market authorization requirements.

Unit 2:

Regulatory Development and Clinical Trial Requirements:

  • Pharmaceutical and biologic regulatory development pathways.

  • Nonclinical requirements and Good Laboratory Practice (GLP).

  • Clinical trial authorizations and Investigational New Drug (IND) provisions.

  • Good Clinical Practice (GCP) and clinical safety reporting.

  • Regulatory authority interactions and submission requirements.

Unit 3:

Quality, Manufacturing, and Regulatory Documentation:

  • Chemistry, Manufacturing, and Controls (CMC) requirements.

  • Good Manufacturing Practice (GMP) and pharmaceutical quality systems.

  • Biologic characterization, comparability, and manufacturing consistency.

  • Process validation, stability, and product specifications.

  • CTD and eCTD regulatory dossier structures.

Unit 4:

Marketing Authorization and Regulatory Lifecycle Management:

  • Marketing authorization pathways, including NDAs and BLAs.

  • Regulatory review procedures and authorization criteria.

  • Biosimilar authorization and scientific requirements.

  • Post-approval variations and regulatory change control.

  • Product labeling, renewals, and authorization maintenance.

Unit 5:

Pharmacovigilance and Regulatory Compliance Governance:

  • Pharmacovigilance and post-marketing safety surveillance.

  • Adverse event reporting and safety signal detection.

  • Risk management plans and REMS requirements.

  • Regulatory inspections and corrective and preventive action (CAPA) principles.

  • Data integrity and regulatory compliance oversight.